These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 22122079)
1. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer. Franci G; Miceli M; Altucci L Epigenomics; 2010 Dec; 2(6):731-42. PubMed ID: 22122079 [TBL] [Abstract][Full Text] [Related]
2. Promises and challenges of anticancer drugs that target the epigenome. Verbrugge I; Johnstone RW; Bots M Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246 [TBL] [Abstract][Full Text] [Related]
3. Targeting epigenetic enzymes for drug discovery. Copeland RA; Olhava EJ; Scott MP Curr Opin Chem Biol; 2010 Aug; 14(4):505-10. PubMed ID: 20621549 [TBL] [Abstract][Full Text] [Related]
4. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Mai A; Altucci L Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. Bhalla KN J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549 [TBL] [Abstract][Full Text] [Related]
6. Targeting DNA methylation in cancer. Szyf M Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240 [TBL] [Abstract][Full Text] [Related]
7. Approaches to target the genome and its epigenome in cancer. Chapman-Rothe N; Brown R Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061 [TBL] [Abstract][Full Text] [Related]
9. Novel approaches on epigenetics. Papait R; Monti E; Bonapace IM Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872 [TBL] [Abstract][Full Text] [Related]
10. Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy. Jazirehi AR Anticancer Drugs; 2010 Oct; 21(9):805-13. PubMed ID: 20679890 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. Schneider-Stock R; Ocker M IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331 [TBL] [Abstract][Full Text] [Related]
12. Chromatin: a key player in complex gene regulation and future cancer therapeutics. Roukos DH Epigenomics; 2011 Aug; 3(4):395-9. PubMed ID: 22126199 [No Abstract] [Full Text] [Related]
13. Epigenetic regulation in cell reprogramming revealed by genome-wide analysis. Hong CP; Park J; Roh TY Epigenomics; 2011 Feb; 3(1):73-81. PubMed ID: 22126154 [TBL] [Abstract][Full Text] [Related]
14. Chromatin-remodelling mechanisms in cancer. Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
16. Unraveling the epigenetic code of cancer for therapy. Smith LT; Otterson GA; Plass C Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396 [TBL] [Abstract][Full Text] [Related]